Science plus technology to address challenges in determining the efficacy of neuroprotective/neurorestorative therapies
Rafael Franco
Exploration of Neuroprotective Therapy ›› 2021, Vol. 1 ›› Issue (1) : 1 -6.
The main challenge in neuroprotection is to demonstrate in humans the efficacy of any neuroprotective therapy. Exploration of Neuroprotective Therapy (ENT) highlights interest in the classical pharmacology, in sophisticated techniques such as deep brain stimulation and in traditional medicine tools (herbal medication, meditation...), etc. While Alzheimer’s disease (AD) and Parkinson’s disease (PD) require neuroprotective interventions to reduce neuronal death whereas amyotrophic lateral sclerosis, spinal cord injuries, autism, etc. may require restoration or both protection and restoration. The challenges are manifold and the 21st century should be able to provide answers to many of the diseases that currently do not have an effective therapy to treat of slow down disease progression.
| [1] |
|
| [2] |
|
| [3] |
|
| [4] |
|
| [5] |
|
| [6] |
|
| [7] |
|
| [8] |
|
| [9] |
|
| [10] |
|
| [11] |
|
| [12] |
|
| [13] |
|
| [14] |
|
| [15] |
|
| [16] |
|
| [17] |
|
| [18] |
|
| [19] |
|
| [20] |
|
| [21] |
|
| [22] |
|
| [23] |
|
| [24] |
|
| [25] |
|
| [26] |
|
| [27] |
|
| [28] |
|
| [29] |
|
| [30] |
|
| [31] |
|
| [32] |
|
| [33] |
|
| [34] |
|
| [35] |
|
| [36] |
|
| [37] |
|
| [38] |
Franco R. Café y salud mental coffee and mental health. Aten Primaria. 2009; 41: 578-81. |
| [39] |
|
| [40] |
|
| [41] |
|
| [42] |
|
| [43] |
|
| [44] |
|
| [45] |
|
| [46] |
|
| [47] |
|
| [48] |
|
| [49] |
|
| [50] |
|
/
| 〈 |
|
〉 |